Donaldson Announces Integrated Lentiviral Manufacturing Platform Development.

Written By Kelli Luginbuhl

Donaldson announces that its Isolere Bio and Univercells Technologies businesses are developing an integrated upstream and downstream platform for viral vector manufacturing. Read the full press release.

 

“This manufacturing platform promises to establish a solution that accelerates process development timelines and reduces manufacturing complexity in the production of accessible cell and gene therapies worldwide,” said Andrew Dahlgren, Donaldson Life Sciences president.

This announcement came as Donaldson with Isolere, Purilogics and Utech are exhibiting at ASGCT at booth 1034.


 

#scaleX #isotag  #bioprocessing #viralvector #biomanufacturing #cellandgenetherapies 

 

Kelli Luginbuhl
Previous

Isolere Bio by Donaldson Launches Research-Grade IsoTag™ AAV Reagent
Next

On-Demand Webinar on Transformative AAV Purification process: Breaking Free from Chromatography. Available Now